Frontal systems deficits in stimulant-dependent patients: evidence of pre-illness dysfunction and relationship to treatment response
Theresa M Winhusen, Eugene C Somoza, Daniel F Lewis, Frankie B Kropp, Viviana Elizabeth Horigian, Bryon Adinoff, Theresa M Winhusen, Eugene C Somoza, Daniel F Lewis, Frankie B Kropp, Viviana Elizabeth Horigian, Bryon Adinoff
Abstract
Background: Frontal systems dysfunction is present in stimulant-dependent patients. However, it is unclear whether this dysfunction is a pre-morbid risk factor or stimulant-induced, is severe enough to be clinically relevant, and if it is relevant to treatment response. These questions were addressed using the Frontal Systems Behavior Scale (FrSBe), a reliable and valid self-report assessment of three neurobehavioral domains associated with frontal systems functioning (Apathy, Disinhibition, and Executive Dysfunction, summed for a Total), that assesses both pre- and post-morbid functioning, and has a specific cutoff for defining clinically significant abnormalities.
Method: Six sites evaluating 12-step facilitation for stimulant abusers obtained the FrSBe from 180 methamphetamine- and/or cocaine-dependent participants. Dichotomous treatment response measures included self-reported stimulant use, stimulant urine drug screens, and treatment completion.
Results: A substantial percentage of participants retrospectively reported clinically significant neurobehavioral abnormalities prior to lifetime stimulant abuse initiation (e.g., 67.5% on FrSBe-Total) with a significant increase in the proportion reporting such abnormalities for current functioning (86% on FrSBe-Total; p<0.0001). Treatment response was significantly worse for participants with, relative to those without, clinically significant Disinhibition as measured by treatment non-completion (31.6% vs. 15.6%, OR=2.51) and self-reported stimulant use during treatment (40.5% vs. 16.7%, OR=3.40).
Conclusion: These findings suggest that frontal systems dysfunction is present prior to stimulant-abuse onset and worsens with stimulant use. Disinhibition may be a prime target for intervention in stimulant-dependent individuals.
Conflict of interest statement
Conflict of Interest
Dr. Adinoff has served as a consultant for Shook, Hardy & Bacon LLP (medical malpractice consultant, tobacco companies). All other authors declare that they have no conflicts of interest.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Source: PubMed